APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biologic Therapeutics Drugs Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchBiologic Therapeutics Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutics Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutics Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Biologic Therapeutics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biologic Therapeutics Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biologic Therapeutics Drugs market include Aurobindo Pharma, Concord Biotech, H. Lundbeck, Retractable Technologies, Smith Medical, AstraZeneca, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biologic Therapeutics Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologic Therapeutics Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologic Therapeutics Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biologic Therapeutics Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologic Therapeutics Drugs Segment by Company

Aurobindo Pharma

Concord Biotech

H. Lundbeck

Retractable Technologies

Smith Medical

AstraZeneca

GlaxoSmithKline

Pfizer

Merck

Novartis

Biologic Therapeutics Drugs Segment by Type

Yeast

Insects Cell Culture

Avian Cell Culture

Bacteria

Transgenics

Biologic Therapeutics Drugs Segment by Application

Diabetes

Anemia

Rheumatoid Arthritis

Cancer

Others

Biologic Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Biologic Therapeutics Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biologic Therapeutics Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biologic Therapeutics Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Biologic Therapeutics Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biologic Therapeutics Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologic Therapeutics Drugs industry.

Chapter 3: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biologic Therapeutics Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biologic Therapeutics Drugs Industry Trends Table 2. Biologic Therapeutics Drugs Industry Drivers Table 3. Biologic Therapeutics Drugs Industry Opportunities and Challenges Table 4. Biologic Therapeutics Drugs Industry Restraints Table 5. Global Biologic Therapeutics Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biologic Therapeutics Drugs Revenue Share by Company (2021-2026) Table 7. Global Biologic Therapeutics Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Biologic Therapeutics Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Biologic Therapeutics Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Biologic Therapeutics Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biologic Therapeutics Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Biologic Therapeutics Drugs Company, Product Type & Application Table 13. Global Biologic Therapeutics Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Yeast Table 18. Significant Companies of Insects Cell Culture Table 19. Significant Companies of Avian Cell Culture Table 20. Significant Companies of Bacteria Table 21. Significant Companies of Transgenics Table 22. Global Biologic Therapeutics Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Biologic Therapeutics Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Biologic Therapeutics Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Biologic Therapeutics Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Biologic Therapeutics Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Biologic Therapeutics Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biologic Therapeutics Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Biologic Therapeutics Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Biologic Therapeutics Drugs Sales Value Share by Type (2021-2026) Table 31. Global Biologic Therapeutics Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Diabetes Table 33. Significant Companies of Anemia Table 34. Significant Companies of Rheumatoid Arthritis Table 35. Significant Companies of Cancer Table 36. Significant Companies of Others Table 37. Global Biologic Therapeutics Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Biologic Therapeutics Drugs Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Biologic Therapeutics Drugs Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Biologic Therapeutics Drugs Sales Volume Share by Application (2021-2026) Table 41. Global Biologic Therapeutics Drugs Sales Volume Share by Application (2027-2032) Table 42. Global Biologic Therapeutics Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Biologic Therapeutics Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Biologic Therapeutics Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Biologic Therapeutics Drugs Sales Value Share by Application (2021-2026) Table 46. Global Biologic Therapeutics Drugs Sales Value Share by Application (2027-2032) Table 47. Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Biologic Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Biologic Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 50. Global Biologic Therapeutics Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global Biologic Therapeutics Drugs Sales Market Share by Region (2027-2032) Table 52. Global Biologic Therapeutics Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Biologic Therapeutics Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Biologic Therapeutics Drugs Sales Value Share by Region (2021-2026) Table 55. Global Biologic Therapeutics Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Biologic Therapeutics Drugs Sales Value Share by Region (2027-2032) Table 57. Global Biologic Therapeutics Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Biologic Therapeutics Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Biologic Therapeutics Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 62. Global Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 63. Global Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Biologic Therapeutics Drugs Sales Market Share by Country (2027-2032) Table 65. Global Biologic Therapeutics Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Biologic Therapeutics Drugs Sales Value Market Share by Country (2021-2026) Table 67. Global Biologic Therapeutics Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Biologic Therapeutics Drugs Sales Value Market Share by Country (2027-2032) Table 69. Aurobindo Pharma Company Information Table 70. Aurobindo Pharma Business Overview Table 71. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio Table 73. Aurobindo Pharma Recent Development Table 74. Concord Biotech Company Information Table 75. Concord Biotech Business Overview Table 76. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Concord Biotech Biologic Therapeutics Drugs Product Portfolio Table 78. Concord Biotech Recent Development Table 79. H. Lundbeck Company Information Table 80. H. Lundbeck Business Overview Table 81. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. H. Lundbeck Biologic Therapeutics Drugs Product Portfolio Table 83. H. Lundbeck Recent Development Table 84. Retractable Technologies Company Information Table 85. Retractable Technologies Business Overview Table 86. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Retractable Technologies Biologic Therapeutics Drugs Product Portfolio Table 88. Retractable Technologies Recent Development Table 89. Smith Medical Company Information Table 90. Smith Medical Business Overview Table 91. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Smith Medical Biologic Therapeutics Drugs Product Portfolio Table 93. Smith Medical Recent Development Table 94. AstraZeneca Company Information Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. AstraZeneca Biologic Therapeutics Drugs Product Portfolio Table 98. AstraZeneca Recent Development Table 99. GlaxoSmithKline Company Information Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio Table 103. GlaxoSmithKline Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pfizer Biologic Therapeutics Drugs Product Portfolio Table 108. Pfizer Recent Development Table 109. Merck Company Information Table 110. Merck Business Overview Table 111. Merck Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Merck Biologic Therapeutics Drugs Product Portfolio Table 113. Merck Recent Development Table 114. Novartis Company Information Table 115. Novartis Business Overview Table 116. Novartis Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Novartis Biologic Therapeutics Drugs Product Portfolio Table 118. Novartis Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Biologic Therapeutics Drugs Distributors List Table 122. Biologic Therapeutics Drugs Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Biologic Therapeutics Drugs Product Image Figure 2. Global Biologic Therapeutics Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biologic Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 5. Global Biologic Therapeutics Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Biologic Therapeutics Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Yeast Image Figure 10. Insects Cell Culture Image Figure 11. Avian Cell Culture Image Figure 12. Bacteria Image Figure 13. Transgenics Image Figure 14. Global Biologic Therapeutics Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Biologic Therapeutics Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Biologic Therapeutics Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Biologic Therapeutics Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biologic Therapeutics Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Biologic Therapeutics Drugs Sales Value Share by Type (2021-2032) Figure 20. Diabetes Image Figure 21. Anemia Image Figure 22. Rheumatoid Arthritis Image Figure 23. Cancer Image Figure 24. Others Image Figure 25. Global Biologic Therapeutics Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Biologic Therapeutics Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Biologic Therapeutics Drugs Sales Volume Share by Application (2021-2032) Figure 28. Global Biologic Therapeutics Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Biologic Therapeutics Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Biologic Therapeutics Drugs Sales Value Share by Application (2021-2032) Figure 31. Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Biologic Therapeutics Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Biologic Therapeutics Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Biologic Therapeutics Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. North America Biologic Therapeutics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Biologic Therapeutics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Biologic Therapeutics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. South America Biologic Therapeutics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Biologic Therapeutics Drugs Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Biologic Therapeutics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Biologic Therapeutics Drugs Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Biologic Therapeutics Drugs Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast
  • Insects Cell Culture
  • Avian Cell Culture
  • Bacteria
  • Transgenics
Applications
  • Diabetes
  • Anemia
  • Rheumatoid Arthritis
  • Cancer
  • Others
Companies covered
  • Aurobindo Pharma
  • Concord Biotech
  • H. Lundbeck
  • Retractable Technologies
  • Smith Medical
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biologic Therapeutics Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Biologic Therapeutics Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Biologic Therapeutics Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biologic Therapeutics Drugs Market Dynamics
  1. 2.1 Biologic Therapeutics Drugs Industry Trends
  2. 2.2 Biologic Therapeutics Drugs Industry Drivers
  3. 2.3 Biologic Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutics Drugs Industry Restraints
3 Biologic Therapeutics Drugs Market by Company
  1. 3.1 Global Biologic Therapeutics Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Biologic Therapeutics Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Biologic Therapeutics Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Biologic Therapeutics Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Biologic Therapeutics Drugs Company Ranking (2024-2026)
  6. 3.6 Global Biologic Therapeutics Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Biologic Therapeutics Drugs Company Product Type and Application
  8. 3.8 Global Biologic Therapeutics Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biologic Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biologic Therapeutics Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biologic Therapeutics Drugs Market by Type
  1. 4.1 Biologic Therapeutics Drugs Type Introduction
  2. 4.1.1 Yeast
  3. 4.1.2 Insects Cell Culture
  4. 4.1.3 Avian Cell Culture
  5. 4.1.4 Bacteria
  6. 4.1.5 Transgenics
  7. 4.2 Global Biologic Therapeutics Drugs Sales Volume by Type
  8. 4.2.1 Global Biologic Therapeutics Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Biologic Therapeutics Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Biologic Therapeutics Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Biologic Therapeutics Drugs Sales Value by Type
  12. 4.3.1 Global Biologic Therapeutics Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Biologic Therapeutics Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Biologic Therapeutics Drugs Sales Value Share by Type (2021-2032)
5 Biologic Therapeutics Drugs Market by Application
  1. 5.1 Biologic Therapeutics Drugs Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Anemia
  4. 5.1.3 Rheumatoid Arthritis
  5. 5.1.4 Cancer
  6. 5.1.5 Others
  7. 5.2 Global Biologic Therapeutics Drugs Sales Volume by Application
  8. 5.2.1 Global Biologic Therapeutics Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Biologic Therapeutics Drugs Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Biologic Therapeutics Drugs Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Biologic Therapeutics Drugs Sales Value by Application
  12. 5.3.1 Global Biologic Therapeutics Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Biologic Therapeutics Drugs Sales Value by Application (2021-2032)
  14. 5.3.3 Global Biologic Therapeutics Drugs Sales Value Share by Application (2021-2032)
6 Biologic Therapeutics Drugs Regional Sales and Value Analysis
  1. 6.1 Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biologic Therapeutics Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Biologic Therapeutics Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Biologic Therapeutics Drugs Sales by Region (2027-2032)
  5. 6.3 Global Biologic Therapeutics Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biologic Therapeutics Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biologic Therapeutics Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biologic Therapeutics Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Biologic Therapeutics Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biologic Therapeutics Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Biologic Therapeutics Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biologic Therapeutics Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Biologic Therapeutics Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biologic Therapeutics Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biologic Therapeutics Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biologic Therapeutics Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Biologic Therapeutics Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biologic Therapeutics Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biologic Therapeutics Drugs Sales Value Share by Country, 2025 VS 2032
7 Biologic Therapeutics Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biologic Therapeutics Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biologic Therapeutics Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Biologic Therapeutics Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Biologic Therapeutics Drugs Sales by Country (2027-2032)
  6. 7.4 Global Biologic Therapeutics Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biologic Therapeutics Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biologic Therapeutics Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biologic Therapeutics Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biologic Therapeutics Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biologic Therapeutics Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 Concord Biotech
  8. 8.2.1 Concord Biotech Company Information
  9. 8.2.2 Concord Biotech Business Overview
  10. 8.2.3 Concord Biotech Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
  12. 8.2.5 Concord Biotech Recent Developments
  13. 8.3 H. Lundbeck
  14. 8.3.1 H. Lundbeck Company Information
  15. 8.3.2 H. Lundbeck Business Overview
  16. 8.3.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
  18. 8.3.5 H. Lundbeck Recent Developments
  19. 8.4 Retractable Technologies
  20. 8.4.1 Retractable Technologies Company Information
  21. 8.4.2 Retractable Technologies Business Overview
  22. 8.4.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
  24. 8.4.5 Retractable Technologies Recent Developments
  25. 8.5 Smith Medical
  26. 8.5.1 Smith Medical Company Information
  27. 8.5.2 Smith Medical Business Overview
  28. 8.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
  30. 8.5.5 Smith Medical Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Biologic Therapeutics Drugs Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Biologic Therapeutics Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Biologic Therapeutics Drugs Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biologic Therapeutics Drugs Value Chain Analysis
  2. 9.1.1 Biologic Therapeutics Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biologic Therapeutics Drugs Sales Mode & Process
  6. 9.2 Biologic Therapeutics Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biologic Therapeutics Drugs Distributors
  9. 9.2.3 Biologic Therapeutics Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst